Skip to main content

Table 6 Risk factors for mortality of renal transplant recipients with mucormycosis

From: Mucormycosis in renal transplant recipients: review of 174 reported cases

Variable

OR (95% CI)

P

Extent of infection

 Localized

Reference

 

 Disseminated

5.41(2.04–14.37)

0.001

Organism

Rhizopus spp.

Reference

 

 Other organisms

 

>0.1

Diabetes

 No

Reference

 

 Diabetes

0.43(0.20–0.89)

0.02

Antifungal therapy

 None

Reference

 

 Amphotericin B deoxycholate

0.30 (0.09–0.97)

0.04

 Lipid amphotericin B

0.10(0.03–0.33)

<0.001

 Posaconazole alone and combined with other antifungals

0.02(0.00–0.22)

<0.01

Surgery

 Surgery as primary therapy

Reference

 

 Without surgery therapy

5.83(2.68–12.70)

<0.001